Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ 36- and 48-month efficacy demonstrated with canaloplasty ➤ Phase 1/2 trial for gene therapy for X-linked retinitis pigmentosa ➤ Topline results from Phase 2a trial for possible DME therapy ➤ Preclinical data shows potential for gene therapy to address Leber congenital amaurosis ➤ ASCRS news and events
➤ Topline results from Phase 3 trials of presbyopia-mitigating drop ➤ Study: Long-term visual outcomes of at-home telemonitoring ➤ AAO IRIS Registry Report ➤ Innovations in capsulotomy technology ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ Roberto Zaldivar, MD, delivers the Steinert Lecture ➤ Richard Lindstrom, MD, gives Obstbaum Lecture ➤ Video cases offer a ‘Reay of Hope’ at Glaucoma Day ➤ Cornea Day covers topics in keratoconus, corneal ectasia, lamellar surgery
➤ FDA approves new phaco system ➤ Next-generation canaloplasty device launch ➤ New Nd:YAG laser launch ➤ Researchers explore non-surgical option to address vision loss ➤ Non-invasive method to examine conjunctival goblet cells in vivo ➤ ASCRS news and events
➤ Phase 3 clinical trials complete for ‘superpotent’ corticosteroid ➤ New rapid, quantitative MMP-9 tear test ➤ First pediatric patient dosed with experimental gene-editing therapy for Leber congenital amaurosis ➤ Study: Comparison of NCX 470 to latanoprost for glaucoma ➤ Collaborations for inherited retinal diseases ➤ ASCRS news and events
➤ FDA approves new ICL ➤ Home tonometer receives 510(k) clearance ➤ First patient treated in what will be the largest standalone MIGS clinical trial ➤ Topline results from second Phase 3 trial of mydriasis-reversing drug ➤ ASCRS news and events
➤ Results from pivotal amblyopia trial ➤ Phase 2 clinical program for third-generation keratoconus treatment ➤ Study compares tolerability of standard drop vs. novel drug delivery device ➤ Phase 3 clinical studies for investigational presbyopia drop complete ➤ Orphan drug designation granted for fungal keratitis treatment ➤ Full rights regained for investigational dry AMD therapy ➤ ASCRS news and events
EyeWorld Glaucoma Editor Nathan Radcliffe, MD, previews the articles in the Glaucoma section of the issue, specifically highlighting some of the advances and changes coming to the field.
While modern angle surgery has been a boon for patients and physicians wishing to avoid or delay more invasive glaucoma procedures and/or reduce the number of topical medications, cyclodialysis cleft, while rare, is still a complication that can occur.
In some glaucoma practices, selective laser trabeculoplasty (SLT) has become a mainstay option at various stages of disease and treatment. However, some ophthalmologists say that despite its diverse utility, SLT adoption has been slow in other practices, and a more recent advancement in related technology could increase adoption.